tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Fate Therapeutics Inc

FATE
Add to Watchlist
1.280USD
-0.060-4.48%
Close 11-13 16:00（ET）
153.37MMarket Cap
LossP/E TTM

Fate Therapeutics Inc

1.280
-0.060-4.48%
Overview
News&Analysis
Financials
Stock Score
Technical
Forecast
Ownership
Dividends
Profile
Discussions
Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial SummaryIncome StatementBalance SheetCash Flow StatementEarningsCompany ValuationRisk Assessment

FATE Financials

See Fate Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Key Financial Ratios
Market Cap
153.37M
Dividend TTM
0.00
P/E TTM
-1.17
EPS TTM
-1.09
Revenue
6.65M
Net Profit
-186.26M
ROE
-55.50%
ROA
-38.01%
Fate Therapeutics Inc Earnings Date
Latest Release
Nov 5, 2026
EPS / Forecast
-0.25/-0.27
Revenue / Forecast
0.00/1.14M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
8.43%-0.25
12.85%-0.25
18.18%-0.26
38.67%-0.27
33.06%-0.27
12.13%-0.29
33.06%-0.32
1.07%-0.44
11.66%-0.40
38.98%-0.33
-146.57%-0.47
22.82%-0.45
---0.46
---0.54
---0.19
---0.58
---2.33
----
----
----
Revenue
-100.00%0.00
9.18%2.08M
-20.26%1.30M
-26.40%1.37M
-43.36%1.74M
-71.84%1.91M
-15.38%1.63M
10.98%1.86M
58.13%3.07M
625.83%6.77M
-96.74%1.93M
-96.22%1.68M
-87.02%1.94M
-94.97%933.00K
220.30%58.98M
159.86%44.36M
5.31%14.98M
38.30%18.55M
65.27%18.41M
7.38%17.07M
Net Profit
4.85%-30.69M
11.48%-30.16M
17.03%-31.21M
37.92%-32.37M
32.36%-32.25M
11.34%-34.07M
21.63%-37.62M
-18.20%-52.15M
-5.55%-47.68M
27.16%-38.43M
-154.25%-48.00M
21.72%-44.12M
45.94%-45.17M
30.68%-52.76M
71.26%-18.88M
17.86%-56.36M
-92.95%-83.56M
-38.04%-76.11M
-45.69%-65.69M
-29.20%-68.62M
Net Margin
----
18.92%-1448.56%
-4.04%-2402.85%
15.66%-2364.79%
-19.43%-1852.38%
-214.85%-1786.58%
7.39%-2309.45%
-6.51%-2803.92%
33.25%-1551.01%
89.96%-567.44%
-7689.80%-2493.71%
-1971.76%-2632.58%
---2323.56%
---5654.34%
---32.01%
---127.07%
---433.85%
----
----
----
Gross Margin
----
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
Debt to assets ratio
--4.99%
--4.57%
--3.71%
----
----
----
----
----
----
--0.00%
----
----
----
----
----
----
----
----
----
----
Income Statement
Revenue
-100.00%0.00
9.18%2.08M
-20.26%1.30M
-26.40%1.37M
-43.36%1.74M
-71.84%1.91M
-15.38%1.63M
10.98%1.86M
58.13%3.07M
625.83%6.77M
-96.74%1.93M
-96.22%1.68M
-87.02%1.94M
-94.97%933.00K
220.30%58.98M
159.86%44.36M
5.31%14.98M
38.30%18.55M
65.27%18.41M
7.38%17.07M
Operating profit
7.16%-32.25M
15.78%-31.13M
20.06%-33.00M
26.14%-34.72M
33.68%-34.73M
18.00%-36.97M
19.17%-41.28M
2.21%-47.01M
-2.14%-52.38M
27.94%-45.08M
-78.61%-51.07M
25.37%-48.08M
40.64%-51.28M
24.72%-62.56M
61.60%-28.59M
7.15%-64.42M
-58.16%-86.39M
-77.66%-83.11M
-61.15%-74.47M
-107.74%-69.38M
Net Profit
4.85%-30.69M
11.48%-30.16M
17.03%-31.21M
37.92%-32.37M
32.36%-32.25M
11.34%-34.07M
21.63%-37.62M
-18.20%-52.15M
-5.55%-47.68M
27.16%-38.43M
-154.25%-48.00M
21.72%-44.12M
45.94%-45.17M
30.68%-52.76M
71.26%-18.88M
17.86%-56.36M
-92.95%-83.56M
-38.04%-76.11M
-45.69%-65.69M
-29.20%-68.62M
Balance Sheet
Current assets
-34.80%144.26M
-31.44%157.95M
-27.67%179.53M
-28.50%208.70M
-28.70%221.25M
-27.86%230.40M
-37.06%248.22M
-11.95%291.91M
-14.80%310.29M
-18.56%319.39M
-9.94%394.38M
-33.97%331.54M
-31.97%364.17M
-34.54%392.18M
-26.91%437.89M
-20.74%502.07M
-22.83%535.33M
-16.00%599.16M
-25.52%599.08M
28.14%633.41M
Total current liabilities
16.29%32.69M
13.67%32.59M
8.98%30.69M
-6.36%36.07M
-24.88%28.11M
-17.59%28.67M
-37.93%28.16M
-1.46%38.52M
-9.46%37.42M
-22.15%34.79M
-6.75%45.37M
-65.72%39.09M
-60.23%41.33M
-51.17%44.69M
-37.56%48.65M
40.31%114.05M
13.12%103.94M
-13.34%91.52M
-17.62%77.91M
-5.00%81.28M
Total assets
-30.67%238.28M
-30.01%260.10M
-28.53%284.92M
-27.63%318.94M
-30.57%343.67M
-29.72%371.63M
-30.04%398.67M
-12.94%440.69M
-8.98%494.97M
-9.57%528.82M
-9.59%569.89M
-28.25%506.22M
-27.43%543.79M
-27.54%584.76M
-26.57%630.34M
-23.43%705.56M
-23.89%749.35M
-20.54%807.06M
-17.93%858.39M
48.04%921.46M
Total liabilities
-3.98%105.24M
-3.27%106.67M
-4.58%105.21M
-8.38%111.75M
-17.37%109.61M
-16.36%110.27M
-23.31%110.26M
-11.49%121.97M
-5.93%132.64M
-10.32%131.84M
-5.94%143.78M
-37.82%137.80M
-39.05%141.01M
-35.12%147.00M
-32.06%152.86M
-8.65%221.62M
-9.00%231.35M
-14.04%226.58M
-12.07%224.99M
1.93%242.62M
Total equity
-43.16%133.03M
-41.29%153.44M
-37.69%179.71M
-35.00%207.18M
-35.40%234.07M
-34.16%261.36M
-32.32%288.41M
-13.49%318.73M
-10.04%362.33M
-9.31%396.98M
-10.76%426.12M
-23.87%368.42M
-22.24%402.78M
-24.59%437.75M
-24.62%477.47M
-28.71%483.94M
-29.07%518.00M
-22.82%580.48M
-19.83%633.39M
76.58%678.84M
Cash Flow Statement
Net operating income
-14.44%-27.89M
4.69%-23.43M
8.83%-30.82M
16.13%-23.31M
17.15%-24.37M
23.89%-24.59M
-1.38%-33.81M
24.12%-27.80M
23.13%-29.42M
-13.38%-32.31M
-15.56%-33.35M
51.40%-36.64M
30.47%-38.27M
46.40%-28.49M
55.33%-28.86M
-7.25%-75.39M
-64.93%-55.05M
-65.57%-53.16M
-138.46%-64.61M
-240.17%-70.29M
Net investment
26.15%26.84M
-25.70%14.56M
-44.73%23.59M
21.10%27.63M
-16.45%21.27M
136.71%19.59M
146.47%42.67M
-49.69%22.82M
2.64%25.46M
-260.92%-53.37M
85.37%17.31M
-14.61%45.35M
-69.14%24.80M
-17.67%33.17M
232.93%9.34M
-25.49%53.11M
3.10%80.38M
3036.37%40.29M
98.51%-7.03M
142.93%71.28M
Net financing
207.92%7.62M
31.02%1.74M
----
-46.01%1.69M
--2.48M
4.00%1.32M
-100.00%0.00
1838.89%3.13M
--0.00
2096.55%1.27M
46029.47%95.49M
-111.87%-180.00K
-100.00%0.00
-98.30%58.00K
-92.60%207.00K
-55.62%1.52M
-81.28%1.49M
-8.42%3.41M
-99.36%2.80M
-30.39%3.42M

FAQs

What is the total revenue of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its total revenue reached 6.65M, with a year-on-year change of 13.63M.

What are the current assets of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its current assets were 208.70M, with a year-on-year change of -28.50.

What are the total assets of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its total assets of Fate Therapeutics Inc were 318.94M, with a year-on-year change of -27.63.

What are the total liabilities of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its total liabilities of Fate Therapeutics Inc were 111.75M, with a year-on-year change of -8.38.

What is the total equity of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its total equity of Fate Therapeutics Inc was 207.18M, with a year-on-year change of -35.00.

What is the net operating income of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its net operating income of Fate Therapeutics Inc was -147.70M, with a year-on-year change of 24.46.

What is the net investment of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its net investment of Fate Therapeutics Inc was 111.17M, with a year-on-year change of 809.85.

What is the net financing of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its net financing of Fate Therapeutics Inc was 5.49M, with a year-on-year change of -94.50.

What is the Earnings Per Share (EPS) of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.15, with a year-on-year change of 29.96.

What is the net income of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its net income was -136.31M, with a year-on-year change of 26.82.

What is the net margin of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its net profit margin was -2051.08, with a year-on-year change of -50.10.

What is the Return on Equity (ROE) of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -51.84, with a year-on-year change of 4.38.

What is the Return on Assets (ROA) of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -35.89, with a year-on-year change of 8.77.

What is the operating profit of Fate Therapeutics Inc?

According to Fate Therapeutics Inc's FY2025 earnings report, its operating profit was -147.70M, with a year-on-year change of 24.46.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy